These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 36010683)

  • 1. Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System.
    Tanaka M; Szabó Á; Spekker E; Polyák H; Tóth F; Vécsei L
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection.
    Sas K; Szabó E; Vécsei L
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29342113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain.
    Deng Y; Zhou M; Wang J; Yao J; Yu J; Liu W; Wu L; Wang J; Gao R
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33535879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the tryptophan-kynurenine axis in association to therapeutic response in clinically depressed patients undergoing psychiatric rehabilitation.
    Reininghaus B; Riedrich K; Dalkner N; Bengesser SA; Birner A; Platzer M; Hamm C; Gostner JM; Fuchs D; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Aug; 94():25-30. PubMed ID: 29753175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
    Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways.
    Oxenkrug G
    Mol Neurobiol; 2013 Oct; 48(2):294-301. PubMed ID: 23813101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
    Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
    Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased fatty acid oxidation and mitochondrial proliferation in liver are associated with increased plasma kynurenine metabolites and nicotinamide levels in normolipidemic and carnitine-depleted rats.
    Lindquist C; Bjørndal B; Lund A; Slettom G; Skorve J; Nygård O; Svardal A; Berge RK
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158543. PubMed ID: 31676443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenine pathway, NAD
    Castro-Portuguez R; Sutphin GL
    Exp Gerontol; 2020 Apr; 132():110841. PubMed ID: 31954874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders.
    Morella IM; Brambilla R; Morè L
    Neurosci Biobehav Rev; 2022 Nov; 142():104892. PubMed ID: 36181925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan-kynurenine profile in pediatric autoimmune hepatitis.
    Lytton SD; Osiecki M; MałgorzataWoźniak ; Cukrowska B; Wierzbicka A; Goliszek M; Socha P; Janczyk W; Dayanakli D; Abendroth D; Kramp S; Fechner K; Scheper T; Mahler M; Bentow C; Bogdanos D; Fuchs D; Woynarowski M
    Immunol Res; 2019 Feb; 67(1):39-47. PubMed ID: 30666511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Emerging Cross-Species Marker for Organismal Health: Tryptophan-Kynurenine Pathway.
    Jamshed L; Debnath A; Jamshed S; Wish JV; Raine JC; Tomy GT; Thomas PJ; Holloway AC
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of Tryptophan Catabolism in Metabolic Syndrome.
    Mallmann NH; Lima ES; Lalwani P
    Metab Syndr Relat Disord; 2018 Apr; 16(3):135-142. PubMed ID: 29406815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity.
    Fitzgerald P; Cassidy Eugene M; Clarke G; Scully P; Barry S; Quigley Eamonn MM; Shanahan F; Cryan J; Dinan Timothy G
    Neurogastroenterol Motil; 2008 Dec; 20(12):1291-7. PubMed ID: 18823288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress.
    Kucukkarapinar M; Yay-Pence A; Yildiz Y; Buyukkoruk M; Yaz-Aydin G; Deveci-Bulut TS; Gulbahar O; Senol E; Candansayar S
    J Neural Transm (Vienna); 2022 Aug; 129(8):1077-1089. PubMed ID: 35796878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity.
    Vidal R; García-Marchena N; O'Shea E; Requena-Ocaña N; Flores-López M; Araos P; Serrano A; Suárez J; Rubio G; Rodríguez de Fonseca F; Colado MI; Pavón FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109958. PubMed ID: 32360814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway.
    Tanaka M; Tóth F; Polyák H; Szabó Á; Mándi Y; Vécsei L
    Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34202246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder.
    Poletti S; Melloni E; Aggio V; Colombo C; Valtorta F; Benedetti F; Comai S
    J Affect Disord; 2019 Dec; 259():404-412. PubMed ID: 31610997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.